Navigation Links
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
Date:8/7/2008

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) will hold a conference call on Monday, August 11, 2008 at 8:30 a.m. EDT to discuss the second quarter 2008 financial results. Michael S. Weiss, Chairman and Chief Executive Officer of the Company, will host the call. Keryx will announce its financial results for this period in a press release to be issued prior to the call.

In order to participate in the conference call, please call 1-877-719-9788 (U.S.), 1-719-325-4769 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference call will be available for replay at http://www.keryx.com, for a period of 15 days after the call.

The press release announcing our financial results for this period will be posted on the Company's website, http://www.keryx.com, prior to the call.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulat
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
2. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
4. Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
5. Keryx Biopharmaceuticals Receives Nasdaq Notification
6. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
7. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
8. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
9. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
11. Keryx Biopharmaceuticals Announces Additions to Management Team

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... This release is available in German . , Wh...ion cards: RFID tags (Radio Frequency Identificati...ay life. They make it possible to label objects or...equency. The appropriate scanner can read and proc...can be affixed to goods under production condition...
(Date:11/24/2009)..., , SANTA CRUZ, Calif., Nov. 24 /PRNewsw...ned Bio Career Center, the nation,s leading online...ssionals. ,, Northwestern and Columbia Universi...her major life science training Institutions. ,...y for post-graduates in the life sciences. While t...
(Date:11/24/2009)... Health care employment g...ns the only one to show consistent growth during t...hospitals remain in trouble, and health systems ar...personnel, instead of just administrators. , ...ealth care employment continued growing in October...
(Date:11/24/2009)..., , SHANGHAI, Nov. 24 /PRNewswire-A...te Food & Drug Administration (SFDA) has appro... for its oral insulin project,(Nodlin), an innovat...D,approval allows Biolaxy to initiate its first ph...order characteristic of high blood glucose and poo...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...horatec,Corporation (Nasdaq: THOR ), a world lead...day reported results for the fourth quarter and,tw...ended December 29, 2007, Thoratec Corporation,repo... percent over,revenues of $214.1 million in fiscal...007 were $64.1 million, a nine percent increase ov...
...armaceuticals,Inc. (Nasdaq: KERX ) today announce...d Chief Executive Officer, will be presenting at t...sday, February 7th, 2008 - 10:20 AM ET:, Merrill ...Medical,Device Conference, Grand Hyatt Hotel ...PM ET: BIO CEO & Investor Conference Waldorf=Ast...
...5 Energy,Conversion Devices, Inc. (ECD) (Nasdaq: ...idiaries, United Solar Ovonic LLC and United Solar...ed revolving credit facility,with an aggregate com...,Agreement and a separate Fast Track Export Loan A...new credit facility consists of two separate,lines...
Other Biology Technology:Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 2Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 3Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 4Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 5Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 6Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 7Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 8Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 9Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 10Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 11Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 12Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 13Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 14Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 15Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 16Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations 2Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements 2
(Date:11/25/2009)... of a lifetime, the heart pumps some 250 million l...o this, the muscle fibers of the heart have to be .... Wolfgang Rottbauer, vice chair of the Department... (Chairman: Prof. Dr. H. A. Katus), has discovered...f the smallest muscular unit, the sarcomere. In co...
(Date:11/25/2009)...hen you eat may be just as vital to your health as...tute for Biological Studies. Their experiments in ...thousands of genes in the liverthe body,s metaboli... and not by the body,s circadian clock as conventi...es the activity of a large number of genes complet...
(Date:11/24/2009)...rch Institute (LRI) today named 12 new grant recip... recognize innovative work across a broad spectrum...eativity, novelty, and potential to drive scientif...e the complex disease of systemic lupus. , The 2...searchers across the nation and include interdisci...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3IFX anti TNF therapy associated with clinical benefit over 5 years in patients with active AS 48757 1IFX anti TNF therapy associated with clinical benefit over 5 years in patients with active AS 48757 2IFX anti TNF therapy associated with clinical benefit over 5 years in patients with active AS 48757 3American Investors Highlight Successes in Eastern Germany 48753 1American Investors Highlight Successes in Eastern Germany 48753 2World Health Organization Declares A 28H1N1 29 Pandemic 48749 1World Health Organization Declares A 28H1N1 29 Pandemic 48749 2World Health Organization Declares A 28H1N1 29 Pandemic 48749 3
... ways to grow brain cells in the laboratory that c...sons disease, an international conference of biolo... (ESF) was told last week. , Professor Ernest Are...nted his research to the EuroSTELLS Stem Cell Nich...l therapy hold the promise of treating disease by ...
...e on Demand,web-hosted employee time and attendanc...the HP WebNet employee time clock. The unique data...shing employee time and,labor data directly to the...ce on Demand. There is no software to install or c...xclusively from Attendance on Demand, extends,the ...
... powerful new tool in the fight against deficienci... including blindness, in 40 million children annua...ion people, mostly in developing countries. , Th... genetic makeup of corn that will enable developin...f corn that has naturally high levels of vitamin A...
Other Biology News:Stem cell research aims to tackle Parkinson's disease 2Web-Hosted Attendance on Demand(R) Introduces Innovative Web Time Clock 2New way to produce high-vitamin corn could improve nutrition in developing countries 2New way to produce high-vitamin corn could improve nutrition in developing countries 3
... functional endoplasmic reticulum (ER) from mammal...eful for protein synthesis, degradation and metabo...R include carnitine acetyltransferase deficiency i...in retention discorders. Suitable for up to 50g of...
pORF-PLAP from InvivoGen
pORF-LacZ from InvivoGen
pORF-eSEAP from InvivoGen
Biology Products: